Cardinal Health, Inc. CAH SPX

Healthcare · Medical Distribution · United States

https://www.cardinalhealth.com

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Market & Price

Market Cap

$46.09B

Current Price

$196.80

High / Low (52W)

$229.32 / $144.85

Beta

0.54

Valuation

Stock P/E

30.05

Industry PE

23.65

Forward P/E

16.43

PEG Ratio

1.22

Book Value

$-12.05

Price to Book

-16.33

P/S

0.18

EV/EBITDA

12.83

Dividend Yield

1.04%

Profitability & Returns

ROCE

16.28%

ROE

ROA

3.60%

Profit Margin

0.62%

Op Margin

1.41%

EPS (Latest Qtr)

$1.69

EPS (TTM)

$6.55

Balance Sheet & Liquidity

Debt/Equity

Quick Ratio

0.42

Current Ratio

0.91

Debt

$8.92B

Total Assets

$53.12B

Current Assets

$36.37B

Working Capital

$-2.52B

Ownership

Promoter Holding

0.26%

Chg in Prom Hold

FII / Inst Holding

89.84%

Chg in FII Hold

-0.01%

Financial Snapshot

Enterprise Value

$51.23B

Total Revenue (TTM)

$250.74B

EBITDA

$3.99B

Free Cash Flow

$4.85B

Operating Cash Flow

$5.00B

Shares Outstanding

234.21M

Gross Margin

3.76%

Payout Ratio

31.19%

Growth (CAGR)

Revenue 5Y

7.07%

Profit 5Y

88.81%

Revenue (YoY)

11.00%

Earnings (YoY)

-19.50%

PROS

Profit CAGR of 88.8% over 5 years.
Generates positive free cash flow.
In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	CAH Cardinal Health, Inc. SPX	196.80	30.05	$46.09B	1.04%	16.28%	-	7.07%	88.81%
2	LLY Eli Lilly and Company SPX	1,105.00	39.21	$985.37B	0.63%	38.44%	107.46%	31.69%	48.96%
3	JNJ Johnson & Johnson SPX	225.33	26.11	$542.42B	2.38%	23.13%	26.42%	5.60%	14.32%
4	UNH UnitedHealth Group Incorporated SPX	380.31	28.66	$345.38B	2.32%	9.60%	12.18%	11.35%	-15.69%
5	MRK Merck & Co., Inc. SPX	118.72	33.44	$293.22B	2.86%	20.66%	18.94%	3.12%	7.93%
6	TMO Thermo Fisher Scientific Inc. SPX	492.51	27.11	$183.03B	0.38%	9.17%	13.52%	-0.27%	-1.19%
7	AMGN Amgen Inc. NDXSPX	336.79	23.42	$181.77B	2.99%	18.02%	101.32%	11.77%	5.58%
8	GILD Gilead Sciences, Inc. NDXSPX	134.43	18.29	$166.90B	2.44%	22.92%	43.36%	2.57%	22.83%
9	ISRG Intuitive Surgical, Inc. NDXSPXAI	424.64	51.53	$150.39B	-	15.96%	17.23%	17.39%	29.26%

Quarterly Results

Figures in USD.

Metric	Jun 2015	Sep 2015	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Sep 2021	Dec 2021	Mar 2022	Sep 2022	Dec 2022	Mar 2023	Sep 2023	Dec 2023	Mar 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	27.55B	28.05B	31.45B	30.66B	31.38B	32.04B	33.15B	31.82B	32.97B	32.64B	35.19B	33.63B	35.35B	35.21B	37.74B	35.23B	37.35B	37.34B	39.73B	39.16B	36.69B	39.06B	41.54B	39.27B	43.97B	45.46B	44.84B	49.59B	51.47B	50.50B	54.65B	57.44B	54.87B	-	-	54.88B	60.16B	64.01B	65.63B	60.94B
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	52.76B	57.96B	61.69B	63.23B	58.44B
Gross Profit	1.46B	1.58B	1.61B	1.69B	1.67B	1.59B	1.60B	1.73B	1.62B	1.67B	1.86B	1.91B	1.74B	1.67B	1.73B	1.76B	1.67B	1.68B	1.71B	1.89B	1.59B	1.72B	1.78B	1.81B	1.64B	1.62B	1.68B	1.60B	1.68B	1.81B	1.74B	1.85B	1.94B	-	-	2.12B	2.20B	2.32B	2.40B	2.50B
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.47B	1.62B	1.56B	1.63B	1.66B
Operating Income	-	620.00M	563.00M	656.00M	-	535.00M	542.00M	605.00M	-	262.00M	399.00M	546.00M	-	816.00M	504.00M	432.00M	-	-5.26B	334.00M	562.00M	-	-624.00M	461.00M	473.00M	415.00M	-950.00M	-97.00M	123.00M	-86.00M	604.00M	-32.00M	505.00M	369.00M	-	-	656.00M	585.00M	754.00M	763.00M	842.00M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	946.00M	667.00M	911.00M	952.00M	741.00M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	74.00M	74.00M	80.00M	88.00M	101.00M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	665.00M	384.00M	598.00M	630.00M	392.00M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	157.00M	141.00M	144.00M	159.00M	12.00M
Net Income	295.00M	383.00M	326.00M	386.00M	333.00M	309.00M	324.00M	381.00M	274.00M	115.00M	1.05B	255.00M	-1.17B	593.00M	280.00M	296.00M	194.00M	-4.92B	220.00M	350.00M	656.00M	-253.00M	629.00M	119.00M	271.00M	49.00M	-1.39B	98.00M	-77.00M	365.00M	-12.00M	368.00M	261.00M	-	-	506.00M	239.00M	450.00M	467.00M	399.00M
Diluted EPS	-	1.15	0.98	1.17	-	-	-	-	-	-	-	-	-	1.94	-	-	-	-16.65	-	-	-	-0.86	-	-	0.94	-	-	0.36	-0.30	1.41	-0.05	1.50	1.07	-	-	2.10	1.00	1.88	1.97	1.69

Profit & Loss (Annual)

Figures in USD.

Metric	Jun 2009	Jun 2010	Jun 2011	Jun 2012	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Revenue	95.99B	98.50B	102.64B	107.55B	101.09B	91.08B	102.53B	121.55B	129.98B	136.81B	145.53B	152.92B	-	181.33B	204.98B	226.83B	222.58B
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	174.84B	198.10B	219.41B	214.41B
Gross Profit	3.75B	3.78B	4.16B	4.54B	4.92B	5.16B	5.71B	6.54B	6.54B	7.18B	6.83B	6.87B	-	6.48B	6.87B	7.41B	8.17B
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	4.84B	5.08B	5.28B	5.85B
Operating Income	1.29B	1.31B	1.51B	1.79B	996.00M	1.89B	2.16B	2.46B	2.12B	126.00M	2.06B	-4.10B	-	1.65B	1.79B	2.13B	2.32B
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	55.00M	1.44B	1.96B	3.11B
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	147.00M	84.00M	51.00M	215.00M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-784.00M	663.00M	1.20B	2.10B
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	153.00M	332.00M	348.00M	532.00M
Net Income	1.15B	642.00M	959.00M	1.07B	334.00M	1.17B	1.22B	1.43B	1.29B	256.00M	1.36B	-3.70B	-	-938.00M	330.00M	852.00M	1.56B
Diluted EPS	3.18	1.77	2.72	3.06	0.97	3.38	3.62	4.32	4.03	0.81	4.53	-12.61	-	-3.35	1.00	3.45	6.45

Compounded Sales Growth

5 Years:	7.07%
1 Year:	11.00%

Compounded Profit Growth

5 Years:	88.81%
1 Year:	-19.50%

Stock Price Performance

1 Year:	+28.87%
6 Months:	-7.47%
3 Months:	-13.94%
1 Month:	-2.97%

Balance Sheet (Annual)

Figures in USD.

Metric	Jun 2008	Jun 2009	Jun 2010	Jun 2011	Jun 2012	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Total Assets	-	-	19.99B	22.85B	24.26B	25.82B	26.03B	30.14B	34.12B	40.11B	39.95B	40.96B	40.77B	-	43.88B	43.35B	45.12B	53.12B
Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	32.94B	33.74B	34.88B	36.37B
Cash & Equivalents	808.80M	1.22B	2.75B	1.93B	2.27B	1.90B	2.87B	4.62B	2.36B	6.88B	1.76B	2.53B	2.77B	-	4.72B	4.08B	5.13B	3.87B
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	15.64B	16.12B	14.96B	16.83B
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10.56B	11.11B	12.08B	13.24B
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	44.58B	46.31B	48.33B	55.76B
Current Liabilities	-	-	11.54B	13.37B	14.17B	14.59B	15.12B	17.24B	19.70B	21.22B	22.89B	24.11B	23.61B	-	30.55B	33.74B	35.64B	38.90B
Long Term Debt	-	-	2.13B	2.50B	-	-	-	-	-	-	-	-	-	-	4.74B	3.91B	4.66B	7.98B
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5.32B	4.70B	5.09B	8.53B
Total Equity	7.75B	8.72B	5.28B	5.85B	6.24B	5.97B	6.40B	6.26B	6.55B	6.81B	6.06B	6.33B	1.79B	-	-709.00M	-2.96B	-3.21B	-2.78B
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	327.00M	327.00M	327.00M	270.68M

Cash Flows (Annual)

Figures in USD.

Metric	Jun 2009	Jun 2010	Jun 2011	Jun 2012	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Operating Cash Flow	1.42B	2.13B	1.40B	1.18B	1.73B	2.52B	2.54B	2.97B	1.18B	2.77B	2.72B	1.96B	-	3.17B	2.84B	3.76B	2.40B
Investing Cash Flow	-542.90M	127.00M	-2.03B	-377.00M	-2.38B	-850.00M	-849.00M	-4.08B	-405.00M	-5.61B	338.00M	493.00M	-	567.00M	-454.00M	-1.85B	-5.59B
Financing Cash Flow	-468.20M	-727.00M	-193.00M	-454.00M	275.00M	-710.00M	60.00M	-1.14B	3.75B	-2.28B	-2.29B	-2.20B	-	-2.46B	-3.05B	-847.00M	1.94B
Capital Expenditure	-421.20M	-260.00M	-291.00M	-260.00M	-195.00M	-249.00M	-300.00M	-465.00M	-387.00M	-384.00M	-328.00M	-375.00M	-	-387.00M	-481.00M	-511.00M	-547.00M
Free Cash Flow	1.00B	1.87B	1.10B	916.00M	1.53B	2.27B	2.24B	2.51B	797.00M	2.38B	2.39B	1.58B	-	2.79B	2.36B	3.25B	1.85B
Net Change in Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	1.28B	-661.00M	1.07B	-1.26B
Share Buybacks	0	230.00M	270.00M	450.00M	450.00M	673.00M	1.04B	651.00M	600.00M	550.00M	600.00M	350.00M	200.00M	1.00B	2.00B	750.00M	765.00M

Ratios (Annual)

Figures in %.

Metric	Jun 2009	Jun 2010	Jun 2011	Jun 2012	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Gross Margin %	3.9%	3.8%	4.1%	4.2%	4.9%	5.7%	5.6%	5.4%	5.0%	5.2%	4.7%	4.5%	-	3.6%	3.4%	3.3%	3.7%
Operating Margin %	1.3%	1.3%	1.5%	1.7%	1.0%	2.1%	2.1%	2.0%	1.6%	0.1%	1.4%	-2.7%	-	0.9%	0.9%	0.9%	1.0%
Net Margin %	1.2%	0.7%	0.9%	1.0%	0.3%	1.3%	1.2%	1.2%	1.0%	0.2%	0.9%	-2.4%	-	-0.5%	0.2%	0.4%	0.7%
ROE %	13.2%	12.2%	16.4%	17.1%	5.6%	18.2%	19.4%	21.8%	18.9%	4.2%	21.5%	-206.6%	-	132.3%	-11.2%	-26.5%	-56.1%
ROCE %	-	15.5%	16.0%	17.8%	8.9%	17.3%	16.8%	17.1%	11.2%	0.7%	12.2%	-23.9%	-	12.4%	18.6%	22.5%	16.3%

Shareholding Pattern

Insiders

0.26%

Institutions

89.84%

Public Float

90.07%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Blackrock Inc.	12.17%	28.49M	$5.61B
2	Vanguard Capital Management LLC	6.53%	15.29M	$3.01B
3	Vanguard Portfolio Management LLC	5.86%	13.73M	$2.70B
4	State Street Corporation	5.16%	12.07M	$2.38B
5	Geode Capital Management, LLC	2.81%	6.58M	$1.30B
6	Morgan Stanley	2.12%	4.95M	$975.01M
7	Wellington Management Group, LLP	1.83%	4.28M	$841.55M
8	FMR, LLC	1.81%	4.24M	$835.07M
9	WCM Investment Management, LLC	1.71%	4.01M	$788.51M
10	Invesco Ltd.	1.50%	3.51M	$691.21M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for CAH

No recent headlines available.

CAH · Healthcare